CAVE CREEK, AZ--(NewMediaWire - Aug 6, 2015) - Endexx
Corporation (OTC PINK: EDXC) is pleased to announce that GreenLeaf
Consulting, a wholly owned subsidiary of Endexx, providing focused
consulting services for medical marijuana license applicants and
industry participants, led a successful bid for Etain, a women
owned enterprise in the state of New York. Etain is one of the five
organizations from forty three applicants that were granted a
license to grow and dispense medical marijuana in the state of New
York.
Joseph Stevens, Founder and President of GreenLeaf Consulting
stated: "I am proud of Etain. They are a strong team of women
motivated by and dedicated to serving the best interests of the
patients of New York. Working with Etain to date has been
rewarding and I look forward to continuing to support them through
the next phases as they ready the operation to serve New York in
January 2016." Mr. Stevens has been working diligently with
Etain over the past year. Mr. Steven's collaboration efforts, based
on high integrity and depth of expertise, helped navigate the
politically charged and complex processes involved. Mr. Steven's
ability to identify and address the critical requirements and
pitfalls in the application process resulted in creating a positive
outcome.
Todd Davis, CEO of Endexx, "Etain has earned the opportunity to
be a leader in the Medical Marijuana business in New York. They
have a tremendous challenge ahead for the next six months as they
prepare to launch their business. The Etain team is a strong and
cohesive group that is especially suited for this endeavor. Endexx
will fully support Greenleaf and Etain and look to further
collaborate to execute the build out of their growing and
dispensing operations."
GreenLeaf Consulting provides consulting and advisory services
to industry participants in several states to assist with
application preparation and securing licensing. Services include
business development, licensing approval, compliance, location
assessment, facility design, security, equipment technology, plant
management, harvesting, processing and packaging protocols. In
addition GreenLeaf Consulting assists clients in formulating a
strategic expansion plan that includes identification of
opportunities and the development of winning strategies.
Etain is a woman owned organization that is run by Amy, Hillary
and Keeley Peckham. Etain is already making plans to renovate a
12,000 square feet barn in Chester, New York for cultivation and
will operate four dispensaries in the state. Licensees only have
six months to open dispensaries and start operations.
About Endexx
Endexx provides innovative medical marijuana management and
technology solutions. Endexx with its collaboration partners and
consultants develops and distributes two consumable product lines
derived from industrial hemp that is organic and naturally rich in
phytocannabinoids. The company has two technology products and
services that launched in 2014 -- the M3hub and the Autospense™.
Both products provide essential solutions to promote regulatory
compliance and full accountability through "seed to sale" inventory
management and tracking. Based on principles developed by the
pharmacological industry, the m3hub platform is the first
standardized software solution for tracking pharmaceutical grade
marijuana to maintain compliance with the laws of National and
State governments, and local regulatory bodies, as well as provide
a smooth transition to the eventual Federal mandates. The
Autospense™ is a high-tech marijuana inventory control and
dispensing machine, which provides up to the minute accounting
details and protects the security of the product as well as the
patient. By automating the dispensing process, Autospense™
increases productivity and reduces costs for marijuana retailers,
while enhancing their service quality by reducing transaction time
for customers. Websites are www.cbdhealthsolutions.com, www.cbdunlimited.com, www.endexx.com, www.m3hub.com.
Safe Harbor Notice
This press release may contain "forward-looking statements"
within the meaning of the Private Securities Litigation Reform Act
of 1995, such as statements relating to financial results and plans
for future development activities, and are thus prospective.
Forward-looking statements include all statements that are not
statements of historical fact regarding intent, belief or current
expectations of the Company, its directors or its officers.
Investors are cautioned that any such forward-looking statements
are not guarantees of future performance and involve risks and
uncertainties, many of which are beyond the Company's ability to
control. Actual results may differ materially from those projected
in the forward-looking statements. Among the factors that could
cause actual results to differ materially from those indicated in
the forward-looking statements are risks and uncertainties
associated with the Company's business and finances in general,
including the ability to continue and manage its growth,
competition, global economic conditions and other factors discussed
in detail in the Company's periodic filings with the Security and
Exchange Commission. The Company undertakes no obligation to update
any forward-looking statements.